Table 4.
Predicted and experimental responses of the optimized nanoformulation.
| Solution | Total lipid-to-MZ ratio | SO-to-compritol ratio | Labrasol (%) | Particle size (nm) | Dissolution efficiency (%) | Inhibition zone (mm) | Desirability |
|---|---|---|---|---|---|---|---|
| Predicted value | 10:1 | 4:4 | 2 | 80.98 | 81.01 | 26.80 | 0.923 |
| Experimental value | 10:1 | 4:4 | 2 | 82 | 84 | 28 | 0.923 |